Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Themis Medicare Ltd

THEMISMED.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$1.10

▲ +0.86%

Market Cap $101.18M · Vol 114.39K

Key Metrics

P/E Ratio

24.21

FWD: N/A

Market Cap

$101.18M

Micro Cap

Div Yield

0.48%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

46.14

Momentum

Beta

1.30

vs Market

52W High

$1.55

34.13% below

52W Low

$0.68

59.59% above

Volume

114.39K

Avg 98.53K

P/B

1.53

Price-to-book

ROE

N/A

Return on equity

Free Float

25.11%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Themis Medicare Ltd (THEMISMED.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does THEMISMED.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.11%

-10.29%

+5.72%

+15.44%

YTD

+4.22%

+3.40%

-44.65%

-7.58%

Financials & Valuation

TTM · Annual

Total Revenue	$36.62M
Net Income	$122.38K
Revenue Growth (YoY)	-10.88%
Gross Margin	59.15%
Operating Margin	-2.90%
Net Profit Margin	0.33%
ROE	N/A
ROA · ROIC	0.33% · 1.52%

P/E Ratio	24.21
Forward P/E (FY1)	N/A
PEG Ratio	-5.72
P/S	1.84
P/B	1.53
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	92.10M

Technical Indicators

50-Day SMA	$1.15
200-Day SMA	$1.04
RSI (14)	46.14
Beta	1.30
52-Week High	$1.55
52-Week Low	$0.68

Volume Today	114.39K
Avg Daily Volume (30D)	98.53K
Relative Volume	1.16x
Volatility (10D)	55.73
Volatility (30D)	43.86
Free Float	25.11%

Analyst Consensus

N/A

Current Price $1.10

Mean Target N/A

52W Low$0.68 52W High$1.55

Current

Target

$0.68 $1.55

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S8HT61

ISININE083B01024

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% ZYDUSLIFE.NS Zydus Lifesciences Ltd -2.75% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56%

Company Profile

Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.